- Home
- CDRE vs BSX Comparison
CDRE vs BSX Comparison
Compare CDRE & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDRE
- BSX
- Stock Information
- Founded
- CDRE 2012
- BSX 1979
- Country
- CDRE United States
- BSX United States
- Employees
- CDRE N/A
- BSX N/A
- Industry
- CDRE Industrial Specialties
- BSX Medical/Dental Instruments
- Sector
- CDRE Health Care
- BSX Health Care
- Exchange
- CDRE Nasdaq
- BSX Nasdaq
- Market Cap
- CDRE 1.3B
- BSX 157.6B
- IPO Year
- CDRE 2021
- BSX 1992
- Fundamental
- Price
- CDRE $32.68
- BSX $98.42
- Analyst Decision
- CDRE Buy
- BSX Strong Buy
- Analyst Count
- CDRE 2
- BSX 22
- Target Price
- CDRE $31.50
- BSX $118.91
- AVG Volume (30 Days)
- CDRE 230.6K
- BSX 7.8M
- Earning Date
- CDRE 11-05-2025
- BSX 10-22-2025
- Dividend Yield
- CDRE 1.14%
- BSX N/A
- EPS Growth
- CDRE N/A
- BSX 36.90
- EPS
- CDRE 0.93
- BSX 1.68
- Revenue
- CDRE $572,607,000.00
- BSX $18,494,000,000.00
- Revenue This Year
- CDRE $12.55
- BSX $19.75
- Revenue Next Year
- CDRE $7.70
- BSX $11.03
- P/E Ratio
- CDRE $35.90
- BSX $58.59
- Revenue Growth
- CDRE 7.66
- BSX 21.44
- 52 Week Low
- CDRE $27.07
- BSX $80.64
- 52 Week High
- CDRE $40.28
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- CDRE 59.78
- BSX 28.32
- Support Level
- CDRE $31.91
- BSX $97.47
- Resistance Level
- CDRE $32.58
- BSX $109.50
- Average True Range (ATR)
- CDRE 0.84
- BSX 2.09
- MACD
- CDRE 0.26
- BSX -1.03
- Stochastic Oscillator
- CDRE 81.44
- BSX 7.88
About CDRE Cadre Holdings Inc.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.